Childhood survivors of high-risk neuroblastoma show signs of immune recovery and not immunosenescence.
Ontology highlight
ABSTRACT: Neuroblastoma survivors show signs of immunosenescence early after therapy in CD8+ T cell compartment and elevated plasma TNF-α but in later follow-up immune recovery comes into play. Whether the recovery phenotype is long lasting or transient remains to be elucidated, however, late adverse effects often occur in childhood cancer survivors.
SUBMITTER: Laznickova P
PROVIDER: S-EPMC7754117 | biostudies-literature | 2020 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA